Peritoneal Phosphate Clearance: Determinants and Association With Mortality

Semin Dial. 2024 May-Jun;37(3):259-268. doi: 10.1111/sdi.13205. Epub 2024 Mar 20.

Abstract

Background: Dialytic phosphate removal is a cornerstone of the management of hyperphosphatemia in peritoneal dialysis (PD) patients, but the influencing factors on peritoneal phosphate clearance (PPC) are incompletely understood. Our objective was to explore clinically relevant factors associated with PPC in patients with different PD modality and peritoneal transport status and the association of PPC with mortality.

Methods: This is a cross-sectional and prospective observational study. Four hundred eighty-five PD patients were enrolled and divided into 2 groups according to PPC. All-cause mortality was evaluated after followed-up for at least 3 months.

Results: High PPC group showed lower mortality compared with Low PPC group by Kaplan-Meier analysis and log-rank test. Both multivariate linear regression and multivariate logistic regression revealed that high transport status, total effluent dialysate volume per day, continuous ambulatory PD (CAPD), and protein in total effluent dialysate volume appeared to be positively correlated with PPC; body mass index (BMI) and the normalized protein equivalent of total nitrogen appearance (nPNA) were negatively correlated with PPC. Besides PD modality and membrane transport status, total effluent dialysate volume showed a strong relationship with PPC, but the correlation differed among PD modalities.

Conclusions: Higher PPC was associated with lower all-cause mortality risk in PD patients. Higher PPC correlated with CAPD modality, fast transport status, higher effluent dialysate volume and protein content, and with lower BMI and nPNA.

Keywords: automated peritoneal dialysis; continuous ambulatory peritoneal dialysis; peritoneal dialysis; peritoneal phosphate clearance; peritoneal transport status.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cross-Sectional Studies
  • Dialysis Solutions
  • Female
  • Humans
  • Hyperphosphatemia* / etiology
  • Kidney Failure, Chronic* / metabolism
  • Kidney Failure, Chronic* / mortality
  • Kidney Failure, Chronic* / therapy
  • Male
  • Middle Aged
  • Peritoneal Dialysis* / mortality
  • Peritoneal Dialysis, Continuous Ambulatory / mortality
  • Phosphates* / analysis
  • Phosphates* / metabolism
  • Prospective Studies

Substances

  • Phosphates
  • Dialysis Solutions